BMO cuts Gildan Activewear stock price target on macro headwinds

BMO Capital reduced its price target on Gildan Activewear (GIL) to $40 from $64, citing softer macro demand. The firm cut its 2026 and 2027 adjusted EBIT estimates by 15% and 17%, respectively. Gildan's stock is down 43.6% year-to-date. The company's Q3 results missed estimates, leading to a lowered full-year 2026 revenue outlook. UBS downgraded GIL to Neutral, while TD Cowen maintained a Buy rating but lowered its target.

Original reporting
Published Nov 9, 2026, 2:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 2:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GIL
Bearish
medium confidence
Mentioned
$GIL
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$GILBearishMed
01

Why it matters

Analyst downgrades and guidance reductions typically trigger short‑term sell pressure, especially after a 19% share drop.

02

Market read

The fresh guidance cuts and earnings miss provide a clear short‑term trading signal for GIL.

03

What to watch

Potential upside from synergies with HanesBrands and a low valuation relative to historical range.

Relevance 6/10Novelty 6/10Timing: post‑earnings today

Background

The article reports analyst price‑target cuts and earnings miss for Gildan Activewear, a mid‑cap apparel maker.

Company-level read

Ticker impact

$GILBearishMedium confidence
Context

BMO cut Gildan Activewear's price target to $40 and highlighted a 19% share decline after Q3 results and weaker guidance.

Expected impact

likely pressure as the market prices in weaker macro demand and reduced guidance.

Evidence & confidence

The price target reduction and earnings miss are fresh disclosures that typically drive short-term sell-offs.

Market effects

Apparel and consumer discretionary sector may see broader weakness as macro demand softens.

North American consumer‑goods stocks could face heightened scrutiny.

Limited to investors tracking mid‑cap apparel names; no immediate global macro effect.

Counterpoint

If the macro headwinds ease faster than expected, GIL could rebound on its still‑intact growth levers.

Key entities

  • BMO Capital Markets

    Lowered GIL price target to $40 and cited macro demand weakness.

  • UBS

    Downgraded GIL to Neutral and cut its price target to $38.

Related articles

$GILMed

Here’s Why UBS Analyst Jay Sole Downgraded Gildan (GIL)

UBS analyst Jay Sole downgraded Gildan Activewear (GIL). Wall Street saw volatility, with $2.3T erased in market value, Nasdaq in correction, and VIX up 70%. Strong jobs data raised Fed rate hike bets to 78%, with 10-year Treasury yield at 4.87%. Analysts predict more hikes, noting wage growth lagging inflation. Historically, VIX spikes preceded S&P 500 gains.

$GILHighAI 8/10

Gildan cuts FY26 outlook after weaker demand weighs on Q3 sales

Gildan (GIL) reduced its FY26 revenue forecast to $5.4bn-$5.5bn from $6.0bn-$6.2bn due to weaker demand. Q3 revenue rose 61.1% YoY to $1.47bn, missing guidance, but adjusted EPS increased 54% to $1.54. The company attributed the shortfall to lower demand and product availability issues, while noting progress in HanesBrands integration.

$GILMed

Gildan cuts 2026 outlook after weaker demand weighs on Q3 sales

Gildan Activewear (GIL) cut its 2026 outlook due to weaker demand, now expecting revenue of $5.4B-$5.5B (down from $6.0B-$6.2B) and adjusted EPS of $3.70-$3.80 (down from $4.65-$4.75). Q3 revenue rose 61.1% YoY to $1.47B, missing guidance, but adjusted operating margin improved to 27%. The company attributed the shortfall to weaker demand and integration challenges from its HanesBrands acquisition.

$GILHigh

UBS downgrades Gildan Activewear stock rating on weak guidance

UBS downgraded Gildan Activewear (GIL) to Neutral, cutting its price target to $38.00 from $71.00 after weak Q3 2026 results and reduced FY 2026 EPS guidance. GIL stock fell 19% post-earnings, trading at $35.02. The company cited softer demand, warm weather, and cautious retail inventory management for its shortfall. UBS sees no catalysts until Spring 2027. FY 2026 revenue outlook lowered to $5.4B-$5.5B from $6.0B-$6.2B.